AbbVie Inc. (ABBV): Dividends Paid
$11.66B
Year ended 2025-12-31
$11.98B
Trailing 12 months to 2026-06-30
+5.1%
3-year compound annual growth
+8.6%
5-year compound annual growth
+13.5%
10-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.66B | +5.7% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $11.03B | +4.6% | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $10.54B | +4.9% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $10.04B | +8.4% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $9.26B | +20.0% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $7.72B | +21.2% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $6.37B | +14.1% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $5.58B | +35.9% | 2021-02-19, From 2018-01-01 |
| 2017-12-31 | $4.11B | +10.5% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $3.72B | +12.8% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $3.29B | +23.8% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $2.66B | +4.1% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $2.56B | n/a | 2016-02-19, From 2013-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| AbbVie Inc. (ABBV) | 2025-12-31 | $11.66B | +5.7% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $5.38B | +15.0% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Organon & Co. (OGN) | 2025-12-31 | $88.00M | -70.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $159.30M | +4.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $19.46M | +0.1% |
Compare ABBV, MRK, LLY, BMY side by side · Screen every company in Pharmaceutical Preparations ↗